MYD88 and colorectal cancer: One such bacterium is Fusobacterium nucleatum which is associated with adverse prognosis and recurrence after chemotherapy (using 5-fluorouracil and oxaliplatin) for colorectal cancer (CRC), which influences molecules such as TLR4 and MYD88, and triggers microRNAs and autophagy mechanisms (56, 202, 203).